LeukoDx Inc. Secures Investment Commitments of up to $8 Million, Closes on the First Tranche of $1.6 Million TOWSON, MD and JERUSALEM, IL--(Marketwire - Apr 18, 2012) - LeukoDx Inc. is pleased to announce it entered into agreements for investments totaling up to $8 million dollars over the next three...

LeukoDx Retains thinXXS to Develop Its Microfluidics Cartridge TOWSON, MD and JERUSALEM and ZWEIBRUCKEN, GERMANY--(Marketwire - November 17, 2010) - LeukoDx Inc. is pleased to announce today that it has retained the services of thinXXS Microtechnology AG to...

LeukoDx Appoints Dr. Bruce Davis as Chief Scientific Officer and Signs MOU for In-Licensing Technology From Trillium Diagnostics TOWSON, MD--(Marketwire - January 12, 2010) - LeukoDx LP is pleased to announce today the appointment of Dr. Bruce Davis, MD as Chief Scientific Officer of LeukoDx. The company is concurrently...